HeartForce is proud to have been selected as a top 5 company for “Patient Monitoring” by Bayer and has been invited to participate in the company’s 2020 Cardiovascular Growth Challenge. HeartForce was selected as one of the finalists from who participated in the Bayer AG Deutschland G4A Partnership program. The G4A Partnership Program offers leading… Continue reading HeartForce Selected as Top 5 Company and Reaches Final Stage of G4A Partnerships Program with Bayer
HeartForce has reached the final round of the 2020 Swiss Innovation Challenge. The challenge is both an innovation funding program and competition, organized by the Chamber of Commerce of Baselland, the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) and the Basellandschaftliche Kantonalbank (BLKB). Twenty-five finalists and one winner will be selected from over… Continue reading HeartForce Enters the Final Round Receives an Award Nomination in the 2020 Swiss Innovation Challenge
Heart Force has been accepted as one of the Top 60 participant teams for the 2020 K-Startup Grand Challenge (KSGC) in Korea. HeartForce was selected from over 2600 applicants from 118 countries. The K-Startup Grand Challenge is a Korean government-led initiative that supports talented local and international tech companies and entrepreneurs with the goal of… Continue reading HeartForce Accepted for 2020 Korea Grand Challenge Accelerator
Essential for monitoring cardiac performance is the assessment of cardiac time intervals (CTIs). With the introduction of gyrocardiography (GCG) as a non-invasive technology for cardiac monitoring, HeartForce investigates the accuracy and reproducibility of estimating CTIs from the GCG recordings of 50 adults.
HeartForce receives ‘Gold’ at German Innovation Awards 2020, with the presentation of the world’s first complete heart-screening device for the early detection and prevention of heart disease. As a leader in innovation and honouring both products and solutions that distinguish themselves primarily by their user centricity, the German Innovation Awards recognized the HeartForce Cardio Pro… Continue reading Cardio Pro Achieves Gold Standard
Using a combination of seismocardiogram (SCG) and electrocardiogram (ECG), HeartForce conducts an analysis on the repeatability of systolic time intervals (STIs) in healthy subjects via two experiments.
Using rest and exercise seismocardiography, HeartForce presents a non-invasive methodology in helping to identify coronary artery disease (CAD), and combating the most common cause of death worldwide. Discover how the fast, easy and inexpensive SCG examination compares to more traditional CAD assessments of exercise electrocardiography (ECG), coronary angiography and coronary computed tomography angiography (CCTA).
In clinical examinations, HeartForce investigated the reliability of cardiac time intervals and beat-to-beat extraction of PCG, ICG and SCG signals in relation to the clinical gold standard of multimodal echocardiography (Doppler, TDI, and M-mode). The three non-invasive methodologies possess the potential to be embedded in wearable devices (ICG, SCG, and PCG), and detect clinically relevant… Continue reading HeartForce Investigates Use of PCG, ICG and SCG in Wearable Devices to Detect Cardiac Time Intervals
In pursuit of identifying the respiratory phases of SCG cycles, HeartForce presents an efficient, reliable and accurate approach in analyzing seismocardiogram cycles to identify the respiratory phases. Results obtained from the study possess the ability to be employed to enhance the extraction of clinically valuable information.
Designing a delineation algorithm, HeartForce investigates the ability to detect specific fiducial points of the seismocardiogram (SCG) signal with or without using the electrocardiogram (ECG). Analysis of the presented algorithm indicates whether the algorithm can be used for accurate and noninvasive estimation of cardiac time intervals.
New methods of recording cardiac timings come to light, sparking renewed interest and novel applications for these cardiac timings. Systolic time intervals have been used to detect and quantify the directional changes of left ventricular function in the past, with new methods now suggesting other alternatives.
Prior research states that peaks on dorsoventral and sternal SCG correspond to specific cardiac events, leading to the potential of extracting such peaks for various types of monitoring and diagnosis applications. However, annotation of these peaks is not a trivial task. Here, HeartForce investigates an automated method to annotate these peaks by using automatic annotation… Continue reading Automatic Annotation of Seismocardiogram